Preeclampsia is a pregnancy-specific disease characterized by concurrent development of hypertension, proteinuria, and oxidative stress in the placenta. In this study, we induced hypoxic stress in rats during pregnancy to reproduce physiological conditions associated with preeclampsia. The maternal weight of hypoxic pregnant rats was lower than that of normoxic animals. The level of calcium ions were also increased in urine collected from the hypoxic animals. In contrast, urinary concentrations of sodium, chloride, and potassium ions declined in hypoxic rats, and developed to proteinuria. The expression of genes known as two biomarkers, sFLT1 (for preeclampsia) and HIF-1alpha (for hypoxia), were highly induced in the placenta, duodenum, and kidney by hypoxic stress. The overexpression of sFLT1 and HIF-1alpha demonstrated that our experimental conditions closely mimicked ones that are associated with preeclampsia. In the present study, we measured the expression of calcium transporters (TRPV5, TRPV6, PMCA1, NCKX3, NCX1, and CaBP-9k) in the placenta, duodenum, and kidney under hypoxic conditions on Gestational Day 19.5 in rats. Placental TRPV5, TRPV6, and PMCA1 expression was up-regulated in the hypoxic rats, whereas the levels of NCX1 and CaBP-9k were unchanged. In addition, NCKX3 expression was increased in the placenta of hypoxic rats. Duodenal expression of CaBP-9k, TRPV5, TRPV 6, and PMCA1 was decreased in the hypoxic rats, whereas levels of NCXs were not altered. Renal expression of NCKX3 and TRPV6 was increased, whereas NCX1 was decreased in the hypoxic rats compared to the normoxic controls. Taken together, these results indicate that physiological changes observed in the hypoxic rats were similar to ones associated with preeclampsia. Expression of calcium transport genes in the placenta, duodenum, and kidney perturbed by hypoxic stress during pregnancy may cause calcium loss in the urine, and thereby induce calcium-deficient characteristics of preeclampsia.
INTRODUCTION
The human placenta is a highly vascularized organ. Its major function is to mediate maternal-fetal exchange of solutes (such as Ca 2þ ) and oxygen. During pregnancy, about 5% of women develop preeclampsia, a condition characterized by hypertension and proteinuria occurring during the second trimester of gestation [1, 2] . Fetal symptoms of this disease include reduced amniotic fluid, abnormal oxygenation, and, in 30% of cases, intrauterine growth retardation. Preeclampsia is a major contributor to maternal and perinatal morbidity and mortality [3] . In preeclampsia, villous injury by trophoblast pseudovasculogenesis retardation is related to poor perfusion/ oxygenation of the intervillous space, uteroplacental hypoxia, and oxidative stress [4, 5] . The precise factors involved in the pathogenesis of preeclampsia remain unclear, because this condition is considered to be a multisystemic disorder [3] . Controlled trials have demonstrated that preeclampsia outcome data and a treatment regimen including calcium supplementation are recommended [6] [7] [8] . However, it is still not clear how calcium supplementation ameliorates preeclampsia. In contrast, more recent reports insist that calcium supplementation is not directly related to the prevention of preeclampsia, although supplementation might have some effects on high-risk populations that are calcium deficient [3, 9] .
The action of calcium ions in female reproductive organs has been widely studied for several decades. It has been suggested that calcium ions are involved in uterine contraction and relaxation and are extremely important throughout pregnancy and during labor [10] [11] [12] [13] . Ca 2þ is crucial for fetal development, and prenatal Ca 2þ levels can affect future disease susceptibility of the fetus [14, 15] . During pregnancy, serum levels of actively ionized calcium do not significantly change, although total serum calcium concentrations decline during gestation [16] [17] [18] . Alterations in maternal Ca 2þ homeostasis have been observed in cases of ischemic placental diseases such as preeclampsia [19] . For this reason, ischemic placental diseases can be theoretically mitigated by increasing duodenal absorption of calcium, decreasing renal calcium losses, and increasing the resorption of calcium from the maternal skeleton [20] .
The duodenum is the site of calcium absorption, the first step of calcium metabolism in the body. This process is mediated by duodenal enterocytes via calcium channels. Therefore, expression patterns of these genes associated with calcium absorption are critical for diagnosing calcium-related placental diseases. In general, calcium absorption is mediated by three types of protein factors. First, calcium entry is regulated by channels such as transient receptor potential cation channel (TRPV) 5 and TRPV6. Second, calciumbinding proteins including calbindin-D 9k (CaBP-9k) and calbindin-D 28k (CaBP-28k) buffer and shuttle intracellular calcium to basolateral surfaces. Third, sodium/calcium exchangers (NCX) such as NCX1 and Na þ /Ca 2þ -K þ exchangers (NCKX3) in the basolateral membrane transport calcium to the blood [13, [21] [22] [23] . TRPV5 and TRPV6 serve as possible gatekeepers for active calcium transport in the epithelium and calcium homeostasis in mammals [24, 25] . CaBP-9k and CaBP-28k are intracellular calcium ion-binding proteins that have been implicated in active calcium absorption [26, 27] . The NCX1 gene is expressed in mammalian tissues and also plays important roles in maintaining calcium homeostasis in many cell types [13, 28, 29] . NCKX3, a potassium-dependent sodium/calcium exchanger, is critical for the transport of one intracellular calcium ion and one potassium ion exchanges with four extracellular sodium ions. Exchangers including NCX1 and NCKX3 are possible for forward and reverse modes of calcium exchange between epithelial cells and extracellular space [12] .
In previous studies, a number of animal models have been produced that mimic some aspects of preeclamptic women [30] [31] [32] [33] . In the animal models of preeclampsia, soluble fmslike tyrosine kinase-1 (sFLT1) is highly expressed [30] [31] [32] [33] ; sFLT1, an antiangiogenic protein, binds to the proangiogenic proteins vascular endothelial growth factor (VEGF) and placental growth factor (PIGF), and thereby prevents interaction with their endothelial cell receptors [31] . VEGF signaling inhibitors have been found to induce hypertension and proteinuria [34] . These secreted soluble factors are thought to alter endothelial metabolic processes, mitochondrial integrity, and vascular function [35] . Genetic models having preeclampsia-like symptoms have also been developed by modulation of preeclampsia-related genes, such as catechol-O-methyltranferase (COMT) and atrial natriuretic peptide-converting enzyme (Corin) [33, 36] . The other preeclampsia-like model was induced by sFLT1 administration in rats [31] .
Hypoxic stress resulting from deficient remodeling of spiral arteries is an important factor for preeclampsia pathophysiology. During preeclampsia, the placenta is exposed to fluctuating oxygen concentrations because of hypoxic stress [37] . Placental hypoxic stress may directly or indirectly lead to oxidative stress in the maternal circulation [38] . This type of stress causes the placenta to release inflammatory cytokines, apoptotic waste, and antiangiogenic factors [39] . Hypoxia can result in temporary brain dysfunction or permanent brain injury, depending on the degree of oxygen deprivation [40] . Under hypoxic conditions, mitochondria in renal tubular cells develop functional deficits that have negative effects such as energy deficits and the promotion of transdifferentiation [41, 42] . Hypoxia also delays the maturation of small intestinal enzymes and may therefore disturb the absorption of nutrients and certain ions including calcium [43] .
In the present study, we hypothesized that hypoxic stress alters the expression of calcium transport genes and contributes to the induction of preeclampsia-like conditions, suggesting that there is a correlation between preeclampsia and the regulation of calcium transport genes. We evaluated isolated tissues and blood from hypoxic rats, and evaluated the effects of the hypoxic stress on the expressions of calcium transporters during pregnancy. In addition, we measured the levels of calcium and several mineral ions in serum and urine from hypoxic pregnant rats.
MATERIALS AND METHODS

Animal Experiments
Mature female pregnant Sprague Dawley rats (.14 wk old) were obtained from Koatech (Pyeongtaek). All animals were housed in polycarbonate cages and acclimated in an environmentally controlled room (23 6 28C, 50% 6 10% relative humidity, frequent ventilation, and a 12L:12D cycle) and rooms with controlled oxygen concentrations (20% 6 2% for normoxia and 12% 6 2% for hypoxia) before use. On Gestational Day (GD) 6.5, the rats were divided into two groups (n ¼ 5 for each group): normoxia (control) and hypoxia. Hypoxic pregnant rats were maintained with a constant inspired fraction of 10% oxygen from GD 6.5 to GD 19.5 (full-term pregnancy is 20.5 days). The pregnant rats were euthanized at GD 19.5. The Ethics Committee of Chungbuk National University approved all animal experimental procedures.
Collection and Biochemical Analysis of Serum and Urine
Blood was collected from each rat, transferred to serum separator tubes (Microtainer tubes; Becton-Dickinson), centrifuged at 400 3 g for 15 min, and aliquoted as 200 ll. Urine was collected for 12 h, and additionally extracted by 1-ml syringe (needle size: 26 gauge) directly from the bladders after open abdominal surgery at euthanasia. Serum and urine analysis included calcium, sodium, potassium, chloride, and total protein (urine only) using an autoanalyzer Hitachi 7080 (Hitachi Science System Ltd.). Urinary albumin and creatinine concentrations were evaluated by using a colorimetric assay in accordance with the manufacturer's recommendations (Sigma-Aldrich). Urine albumin excretion was estimated as the quotient of urine albumin and creatinine as previously described [44] .
Blood Collection and Blood Gas Analyzing
Blood samples assayed by the reference laboratory (OPTI Medical) were drawn into 1-ml syringes with 10 IU heparin (JW Pharmaceutical), then packaged with ice and sealed with a cap before use. The OPTI-CCA (OPTI Medical) calculated total bicarbonate (HCO 3 À ) from the measured potential hydrogen (pH). Partial pressure of carbon dioxide (pCO 2 ), partial pressure of oxygen (PO 2 ), base excess (BE), total carbon dioxide (tCO 2 ), HCO 3 À , buffer base (BB), oxygen content (O 2 ct), and oxygen saturation (saO 2 ) were measured using an OPTI-CCA Blood Gas and Electrolyte Analyzer (OPTI Medical).
Blood Pressure Measurements
The blood pressure of each pregnant rat was taken on GD 6.5 and 19.5 using the noninvasive tail-cuff method (LE5002, Panlab). Each pregnant rat was pretrained for 3 consecutive days prior to the Day 0 blood pressure measurement to minimize stress reactions. On GD 6.5 and 19.5, each pregnant rat was housed in an individual metabolic cage (Panlab).
Total RNA Extraction and Quantitative Real-Time PCR Following euthanasia of the rats, the duodenum, kidney (whole), and placenta (whole) were rapidly excised and washed in cold sterile saline (0.9% NaCl). Total RNA was prepared using TRIzol reagent (Invitrogen) and RNA concentrations were determined by measuring the absorbance at 260 nm. Total RNA (1 lg) was reverse transcribed into first-strand cDNA using Moloney murine leukemia virus reverse transcriptase (Intron Bio) and random primers (9-mers; Takara Bio). The cDNA template (2 lL) was added to 10 lL of 23 SYBR Premix Ex Taq (Takara Bio) containing 10 pmol of the specific primer pairs as previously described [29] . Reactions were carried out for 40 cycles of denaturation at 958C for 30 sec, annealing at 608C for 30 sec, and extension at 728C for 45 sec. Fluorescence intensity was measured at the end of the extension phase of each cycle. The threshold fluorescence intensity for all samples was manually set. The reaction cycle at which the PCR products exceeded this threshold was identified as the threshold cycle (CT) of the exponential phase of PCR amplification. The expression of TRPV5, TRPV6, plasma membrane Ca 2þ ATPase1 (PMCA1), NCKX3, NCX1, CaBP-9k, and sFLT1 was quantified relative to that of HPRT1. Quantification was performed by comparing CT values at constant fluorescence intensity. The amount of transcript is inversely related to the observed CT, and for every 2-fold dilution of the transcript, the CT is expected to increase by one increment. Relative expression (R) was calculated using the equation R ¼ 2 À [DCT sample À DCT control]. To identify a normalized arbitrary value for each gene, each value obtained was normalized to the expression of HPRT1.
Western Blot Analysis
Following euthanasia of the rats, the duodenum, kidney (whole), and placenta (whole) were rapidly excised and washed in cold sterile saline (0.9% NaCl). Proteins were extracted using Pro-prep (Intron) according to the manufacturer's instructions. Tissue homogenates were prepared by 20 strokes with a Dounce homogenizer (Ika-Vibrax-VXR, IKA Werke GMBH) followed YANG ET AL.
by centrifugation at 13 000 3 g for 20 min at 48C. Total proteins (30 lg per lane) was separated in a 10% SDS-PAGE gel and transferred to a polyvinylidene fluoride membrane (PerkinElmer) in a TE-22 TransBlot Cell (Hoefer) according to the manufacturer's instructions. The resulting blot was blocked with Tris-buffered saline containing 0.5% Tween-20 (TBS-T) containing 5% skim milk for 60 min, then incubated with primary antibodies against the following factors: anti-TRPV5 (goat polyclonal, 1:500; Santa Cruz Biotechnology), anti-TRPV6 (goat polyclonal, 1:500; Alomone Labs), anti-NCKX3 (goat polyclonal, 1:500; Santa Cruz Biotechnology), anti-NCX1 (1:500; Santa Cruz Biotechnology), anti-CaBP-9k [29] , PMCA1 (rabbit polyclonal, 1:500; SWANT) and anti-HIF-1a (mouse polyclonal, 1:500; Santa Cruz Biotechnology). The resulting blot was blocked with TBS-T containing 5% skim milk for 60 min with horseradish peroxidase-conjugated secondary antibody (anti-goat, 1:200, or anti-rabbit, 1:5000; Santa Cruz Biotechnology), each a blot for 1 h at room temperature. The blots were developed by incubation with an ECL chemiluminescence reagent (Santa Cruz Biotechnology) and were subsequently exposed to Biomax Light film (Kodak) for 1-5 min. Signal specificity was confirmed by blotting without primary antibody, and bands of interest were normalized to b-actin visualized on the same membrane after stripping. Signal intensity for each band was measured using NIH ImageJ software (National Institutes of Health). Background signal from an area near each lane was subtracted from each band to obtain the mean band density. Significant differences were analyzed using a one-way ANOVA (Prism 4 GraphPad; GraphPad Software).
Immunohistochemical Staining
Calcium transports were observed by immunohistochemistry. Placenta, duodenum, and kidney tissues were embedded in paraffin before sectioning (5 lm thick), deparaffinized in xylene, and hydrated in descending grades of ethanol. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide in TBS-T for 30 min. Nonspecific reactions were blocked by incubating the sections in 10% normal goat serum for 2 h at room temperature. Sections were subsequently incubated at room temperature for 4 h with antibodies against TRPV6, NCKX3, NCX1, CaBP-9k (goat polyclonal, 1:300; Santa Cruz Biotechnology), or PMCA1 (rabbit polyclonal, 1:500; SWANT) diluted in 10% normal goat serum. After washing with TBS-T, the sections were incubated with a biotinylated secondary antibody (goat IgG or rabbit IgG; Vector Laboratories) for 30 min at 378C and then incubated with ABC Elite (Vector Laboratories) for 30 min at 378C. Diaminobenzidine (Sigma-Aldrich) was used as a chromogen and the sections were counterstained with Harris hematoxylin (Sigma-Aldrich) before mounting in Canada balsam (SigmaAldrich).
Data Analysis
Results of blood pressure, weight(s), ion concentrations, serum and urine chemistry, and blood gas analyses are presented as means 6 SEM. The results of gene expression are shown as means 6 SD. Differences between two groups were analyzed with a Student t-test. Statistical analyses were performed using Prism GraphPad software (v4.0). P values , 0.05 were considered to be statistically significant.
RESULTS
Phenotypic Characterization of Hypoxic Pregnant Rats
Although preeclampsia is a serious condition that can lead to maternal and fetal death during pregnancy, the underlying mechanism and precise cause are not still understood because of the lack of an appropriate experimental model. In the present study, we used hypoxic rats to mimic preeclamptic conditions and evaluated mechanisms that directly or indirectly cause preeclampsia. Hypoxic stress was induced in the pregnant rats from GD 6.5 to GD 19.5. The maternal blood pressure was measured on GD 6.5 (baseline) and GD 19.5. Daily food intake along with body weights of the mother and fetus were also determined. Hypoxic conditions resulted in marked increases in mean arterial pressure, which rose from 97 6 7 to 148 6 9 mm Hg after 9 days of hypoxia condition during pregnancy. The blood pressure of normoxic rats was not significantly changed during gestation. Maternal body weight was significantly decreased after a reduction of maternal food intake under hypoxic conditions was observed, and fetal weight was moderately decreased (Table 1) .
Because proteinuria is a key symptom of preeclampsia [39] , we also estimated the concentration of total protein and albumin:creatinine ratio in the urine to determine whether hypoxic stress actually induced preeclampsia-like conditions in our experimental model. Protein was not detected in the urine of normoxic rats, which is physiologically normal. In contrast, hypoxic stress induced the excretion of protein in urine, and the albumin:creatinine ratios were elevated in hypoxic stressed pregnant rats as described in Table 1 . The levels of calcium, sodium, potassium, and chloride ions in the serum and urine of normoxic and hypoxic rats were also measured because the concentrations of these ions are used for diagnosing preeclampsia [45] . In the hypoxic pregnant rats, urine calcium levels were increased up to 1.8-fold, whereas neither sodium nor chloride ions were detected. Conversely, serum concentrations of all the tested ions were not significantly altered (Table  2 ). Blood gas concentrations were also analyzed. The results showed that the levels of pH, pCO 2 , BE, tCO 2 , HCO 3 À , BB, and O 2 ct were decreased in blood under hypoxic conditions (Table 3 ). In contrast, the levels of pO 2 and saO 2 were unchanged in the hypoxic rats compared to their normoxic counterparts.
Expression of Calcium Transport-Associated Genes in the Placenta of Hypoxic Rats
Although the mechanism and causes of preeclampsia are not clear, there are genes that can serve as biomarkers to diagnose CALCIUM TRANSPORTERS REGULATED IN PREECLAMPSIA preeclampsia or hypoxic stress, such as sFLT1 or HIF-1a in the placenta [31] . In the present study, we measured sFLT1 and HIF-1a gene expression to verify that hypoxic stress can induce physiological conditions similar to those associated with preeclampsia. The expression of sFLT1 and HIF-1a in the placenta, duodenum, and kidney was significantly increased by hypoxic stress (Fig. 1) , suggesting that our experimental conditions were close to those of preeclampsia. Because the calcium, sodium, and chloride concentrations in the urine were modulated by hypoxia, we also analyzed the expression levels of genes that affect calcium absorption in the placenta, duodenum, and kidneys. The expression of two calcium influx channels (TRPV5 and TRPV6), a reflux channel (PMCA1), an intracellular calcium buffering protein (CaBP9k), and two sodium/calcium exchangers (NCX1 and NCKX3) in the placenta was first examined. Both the mRNA and protein levels of TRPV5, TRPV6, and PMCA1 (Fig. 2) were significantly increased with hypoxia in the placenta. Placental NCKX3 expression was slightly increased, whereas the levels of NCX1 and CaBP-9k were unchanged under hypoxic conditions (Fig. 3) . These results indicate that the expression of placental calcium transport genes such as TRPV5, TRPV6, PMCA1, and NCKX3 was up-regulated by hypoxic stress, and may be involved in maintaining calcium balance between maternal and fetal calcium demand.
Expression of Calcium Transport-Associated Genes in the Duodenum of Hypoxic Rats
The mRNA and protein levels of TRPV5, TRPV6, PMCA1, NCX1, NCKX3, and CaBP-9k were analyzed on GD 19.5 in the placentas of normoxic and hypoxic rats by real-time PCR and Western blot. Both the mRNA and protein levels of TRPV5 and TRPV6 (Fig. 4A ) in the duodenum were decreased, along with PMCA1 (Fig. 4B) , under hypoxic conditions. CaBP-9k expression was also significantly decreased, whereas the levels of NCX1 and NCKX3 were unchanged (Fig. 5) . These results indicate that calcium concentrations in the hypoxic rats may be decreased relative to those of normoxic rats by down-regulating the expression of calcium influx channels and intracellular calcium-buffering genes.
Expression of Calcium Transport-Associated Genes in the Kidney of Hypoxic Rats
To investigate the mechanism underlying increased urine calcium concentrations in the hypoxic rats (Table 2) , we measured the expression of genes associated with calcium transport in the kidney. The expression patterns of these genes were different compared to those observed in the duodenum. TRPV6 expression was significantly increased (up to 1.8-fold) in the hypoxic rats, whereas no significant changes were observed for TRPV5 or PMCA1 (Fig. 6) . Although CaBP-9k expression was unaffected, hypoxic stress moderately decreased NCX1 and significantly increased NCKX3 gene expression (up to 10-fold; Fig. 7 ).
Localization of Calcium Transporter Expression in the Placenta, Duodenum, and Kidney of Hypoxic Pregnant Rats
To examine the spatial expression of calcium transport proteins in the placenta, duodenum, and kidney, we immunostained tissue sections with antibodies against various calcium transporters as shown in Figures 8 and 9 . TRPV6, PMCA1, NCX1, and NCKX3 were observed in the intraplacental yolk sac epithelium (IPYS), and also localized in trophoblasts (both CALCIUM TRANSPORTERS REGULATED IN PREECLAMPSIA monotrophoblast and syncytiotrophoblast) of the labyrinthine zone. The localization of TRPV5 and CaBP-9k was restricted in the epithelium of maternal blood vessel and IPYS, respectively (Fig. 8) . TRPV5, TRPV6, NCX1, NCXK3, and CaBP-9k were abundantly expressed in the distal and proximal convoluted tubules as shown in Figure 9 . TRPV6 and CaBP-9k were more highly expressed in the proximal convoluted tubules compared to the distal convoluted tubule layer in both normoxic and hypoxic animals. NCX1 and NCKX3 proteins were primarily found in the basolateral layer of the distal convoluted tubules, and were not detected in the glomerulus of the kidney of either normoxic or hypoxic pregnant rats. In addition, all calcium transport proteins we studied were highly expressed in the brush border membrane of the duodenum during pregnancy in all animals.
DISCUSSION
Preeclampsia is a serious medical condition that develops during pregnancy and characterized by villous injury due to trophoblast pseudovasculogenesis retardation associated with poor perfusion/oxygenation of the intervillous space, uteroplacental hypoxia, and oxidative stress [4, 5] . In the present study, we exposed pregnant rats to hypoxic stress that was hypothesized to induce conditions similar to those of preeclampsia. We then examined the expression of calcium transporters in the placenta, duodenum, and kidney, and evaluated the physiological effects of hypoxia by measuring changes in serum and urine biochemistry, blood gas composition, and body weight.
In cases of preeclampsia, the elevated production of the antiangiogenic factors sFLT1 and HIF-1a is related to gestational imbalances and contributes to preeclamptic symptoms such as proteinuria, endotheliosis, and edema [31, 46] . These proteins have therefore been suggested to be biomarkers of preeclampsia [31, 47] . In a previous study, similar in vivo models of preeclampsia were created, including ones for examining uteroplacental ischemia, chronic nitric oxide synthase inhibition, and VEGF inhibition [48] . In all of these systems, sFLT1 and HIF-1a expression is greatly increased and accompanies proteinuria development [30] . In our study, two markers of preeclampsia or hypoxic stress, sFLT1 and HIF-1a, were highly expressed in the placenta, duodenum, and kidney of hypoxic pregnant rats compared to normoxic controls. Our animal model also developed proteinuria, a feature of preeclampsia and a potentially severe complication of pregnancy [31, 49] . These findings suggest that our experimental hypoxic conditions induced physiological and biochemical CALCIUM TRANSPORTERS REGULATED IN PREECLAMPSIA conditions that promote preeclampsia. It has also been demonstrated by other groups that hypoxia is correlated with hallmark features of preeclampsia, inducing trophoblast cell death, the release of proinflammatory cytokines, and oxidative stress [50, 51] .
In our rat model, we observed maternal weight loss and decreasing food intake with hypoxia (for 2 wk) compared to baseline values. In previous studies, hypoxia was found to cause anorexia and subsequent weight loss [52, 53] . These findings suggest that hypoxic stress may reduce maternal body weight because of decreased food intake; however, it is not tightly involved in the development of preeclampsia. Hypoxic pregnant rats also suffered from hypercalciuria and metabolic acidosis, characterized by increased urinary calcium excretion and reductions of pH, pCO 2 , HCO 3 À , BB, BE, and O 2 ct levels in whole blood. In previous investigations, reduced calcium excretion was observed in preeclamptic women [3, 54, 55] . Differences between these results and our data suggest that the hypoxia-stressed animals we used were not completely accurate models of preeclampsia. Although calcium excretion in urine is not a traditional symptom of preeclampsia [3, 54, 55] , there is some evidence showing calcium excretion [56, 57] . Urinary calcium excretion and blood gas levels are also indicative of metabolic acidosis, as previously described [58] . It has been reported that metabolic acidosis can lead to increased bone calcium efflux and urinary calcium excretion [59, 60] , conditions that are linked to osteoporosis, diabetes, kidney stones, and preeclampsia [58, 61] .
The preliminary findings from our study, including the observations that proteinuria, metabolic acidosis, and enhanced sFLT1 and HIF-1a gene expressions were induced by hypoxic stress in the pregnant rats, prompted us to evaluate variations of blood calcium levels and the expression of calcium transport proteins.
Calcium ions are known to act as negatively charged buffers that prevent blood acidification [62] . Calcium supplementation can help to prevent serious disorders such as hypercalcemia and hypocalcemia by helping restore the optimal balance between calcium absorption and loss [16, 58] . When calcium requirements of the body increase, calcium ions are removed from the bones, kidneys, and duodenum through calcium transporters such as CaBP-9k, TRPV5, TRPV6, PMCA1, and NCX1 [63] [64] [65] . We evaluated the differential expression of calcium transporters in the duodenum, kidney, and placenta of hypoxic pregnant rats. TRPV6, PMCA1, NCX1, and NCKX3 were primarily localized in the trophoblasts of the labyrinthine zone and IPYS. In contrast, TRPV5 and CaBP-9k expression was restricted to the epithelium of maternal blood vessel and IPYS. In the kidney, TRPV5, TRPV6, PMCA1, NCX1, NCKX3, and CaBP-9k were principally expressed in the basolateral layer of the distal and proximal convoluted tubules. These proteins were also found in the duodenal brush border membrane layer. Convoluted tubules and the brush membrane have already been shown to express several calcium transporters [66] [67] [68] . The calcium transporters we evaluated are thought to function collectively as gatekeepers for active calcium transport in the placenta, duodenum, and kidney [29, 63, [69] [70] [71] .
The expression of TRPV5, TRPV6, PMCA1, and NCXK3 was increased under hypoxic stress, whereas NCX1 and CaBP9k levels were not altered in the placenta of pregnant rats (on GD 19.5). These results indicate that alteration of calcium transport gene expressions in the placenta of hypoxic rats influences maternal-fetal calcium transport mechanisms. Other studies have also demonstrated that calcium transport genes are expressed in rodent placenta [72, 73] . In addition, TRPV5, TRPV6, NCX1, and CaBP-9k expression has previously been found in placental trophoblasts [29] . In another previous study, TRPV6 expression was identified in mouse uterus, labyrinthine and junctional zones of the placenta, and fetal membrane during pregnancy [24] . Uterine and placental TRPV6 expression support the hypothesis that TRPV6 participates in transporting calcium ions between the maternal and fetal individual space [74] . In addition, CaBP-9k expression was induced concurrently with increased fetal calcium demand [44, 75] . The role of NCX1 in transplacental movement of calcium from mother to fetus was observed in perfusion studies of human placental lobules [76] . TRPV5, TRPV6, PMCA1, NCX1, NCKX3, and CaBP-9k were also found to colocalize in luminal epithelial cells of the uterus, kidney, and/or duodenum [22, 25, 28, 63, 77] . Findings from our study suggest that alteration of calcium transport gene expressions may be involved in maternal-fetal calcium transport. This could represent a calcium influx/reflux mechanism that is critical for maintaining maternal and fetal calcium homeostasis in cases of preeclampsia.
In the duodenum, the expression of TRPV5, TRPV6, PMCA1, and CaBP-9k was reduced in the hypoxic rats, whereas NCKX3 and NCX1 levels were unchanged. These findings suggest that hypoxic stress may reduce calcium absorption by decreasing calcium influx (TRPV5 and TRPV6), reflux (PMCA1), and buffering (CaBP-9k) in the duodenum. Given the down-regulated expression of calcium transport genes in the duodenum, we expected to observe reduced of calcium levels in the blood. However, we found that calcium blood concentrations were not significantly affected by hypoxic stress. It is possible that the levels of calcium in the blood were balanced by bone resorption.
Renal NCKX3 and TRPV6 levels were increased up to 10-or 1.8-fold, respectively, in the kidney of hypoxic pregnant rats, whereas NCX1 expression decreased. NCKX3 plays a critical role in calcium ion extrusion by transporting one intracellular calcium ion with four extracellular sodium ions [12, 78] . NCKX transport functions have been described in human embryonic kidney cells (HEK293), suggesting that NCKX is associated with calcium extrusion [79, 80] . In the present study, biochemical analysis showed that hypoxia resulted in high levels of calcium excretion whereas sodium and chloride were not detected in the urine. It is possible that augmented expression of NCKX3 stimulates the process of calcium/sodium exchange in the kidney, and thereby increases calcium excretion and sodium reabsorption. A previous report also demonstrated that the exchange activity of NCKX3 is closely reflected by sodium ion concentrations [80] . Furthermore, the mechanisms of sodium and chloride transport are linked to each other [81, 82] . The high concentrations of calcium we observed along with our inability to detect sodium or chloride ions may be correlated with NCKX3 overexpression in the kidney.
Whereas renal NCX1 expression was decreased 2-fold in the hypoxic rats compared to the normoxic control, TRPV6 expression was elevated under hypoxic conditions. Previous studies have found that TRPV6 and CaBP-9k appear to be involved in calcium absorption [63, 68, 83] or reabsorption [65, 84] . Similar to a previous investigation [85] , we observed reduced calcium influx in the proximal tubules of the kidney after urine calcium levels were increased by hypoxia. Our results demonstrated that calcium is not reabsorbed in the kidney with hypoxic stress and is excreted in the urine. In addition to the duodenum, changes of calcium transport gene expression in the kidney indicated that hypoxic stress led to a loss of calcium ions and subsequent imbalances. This was YANG ET AL.
caused by modulation of intracellular calcium entry channels, calcium binding proteins, and basolateral exit exchangers, leading to metabolic disturbances in the rats during pregnancy.
In summary, we generated a model of hypoxia in pregnant rats that shares clinical similarities with humans suffering from preeclampsia or other metabolic diseases such as proteinuria, metabolic acidosis, and hypercalciuria. We further demonstrated that the expression of calcium transporters in the placenta, duodenum, and kidney of pregnant rats is differentially regulated under hypoxic conditions. Our results also showed that these changes cause calcium deficiencies associated with preeclampsia. Findings from the current study may contribute to a better understanding of the interrelationship between calcium imbalances and metabolic disturbances during preeclampsia pathogenesis.
